Disruptive Pharma AB
Maria Stromatia has extensive experience in group procurement and demand management at the National Bank of Greece, where responsibilities include reporting, financial and cost analysis, vendor valuation, approvals administration, and managing SLAs since January 2014. Prior roles include customer service representative at Cosmote e-Value in 2013, human resources staffing coordinator at Art Profile from 2011 to 2013, and assistant to the manager at Axia Financial Services from 2008 to 2010, providing office management and secretarial support. Maria Stromatia holds a Master of Science in Business Administration with a focus on Finance, Banking, and Insurance from Elliniko Anoikto Panepistimio (2017-2019) and a Bachelor of Business Administration from Technological Educational Institute of Chalkida (2004-2009).
This person is not in any offices
Disruptive Pharma AB
Disruptive Pharma is a pharmaceutical company that develops novel drug products by applying a unique drug delivery technology. We develop selected drug products based on our proprietary drug delivery platform, the pharma-grade mesoporous magnesium carbonate (Pharma-MMC). The Disruptive Pharma company has offices in both Uppsala (HQ) and Stockholm. By a clever combination of already approved active pharmaceutical ingredients (APIs) with Pharma-MMC platform, several unique opportunities to realize highly valuable therapeutically equivalent or improved drug products emerges. The Pharma-MMC drug delivery technology can be used to create amorphous solid dispersions of the drug, hence increasing its dissolution and the body’s ability to absorb the drug, and may be used to rescue particularly difficult drugs or to enable novel product formulations Disruptive Pharma is a spin-out from the company Disruptive Materials that is located in Uppsala. The company is well-positioned to exploit its pioneering discovery of a unique mesoporous magnesium carbonate (MMC) material. Up until breakthrough discovery by the group of Professor Maria Strømme in 2012, commercialized by Disruptive Materials AB in 2013.